Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy
09 sept. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today new data and the filing of a patent application covering the...
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer
03 sept. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the recruitment of Feng Lin, MD, Ph.D., as...
Therapeutic Solutions International Inc. Reports Revenues Up 850% for Q2
29 août 2019 13h53 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Therapeutics Solutions International Inc. (OTC: TSOI) today reports that its second-quarter 2019 revenues increased 850%, as...
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
26 août 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
05 août 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) together with The Right to Try Foundation announced filing of a...
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer
29 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal data demonstrating synergy at...
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer
22 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) reported today positive animal data demonstrating synergy...
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release in Prostate Cancer
15 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Therapeutic Solutions International, Inc. (OTC Markets: TSOI) announced today the addition of nano particle cannabidiol to NanoMyros in the form...
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of NanoPSA
11 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the further development of a mustard seed...
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
08 juil. 2019 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the development of a broccoli sprout extract...